1. Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS
   Gil Pinheiro et al, 2020, Scientific Reports CrossRef
2. Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing
   Gou Yamamoto et al, 2017, International Journal of Oncology CrossRef
3. Relationship of radiometabolic biomarkers to KRAS mutation status and ALK rearrangements in cases of lung adenocarcinoma
   Gulfidan Aras et al, 2019, Tumori Journal CrossRef
4. Relationship of Radiometabolic Biomarkers to KRAS Mutation Status and ALK Rearrangements in Cases of Lung Adenocarcinoma
   Gulfidan Aras et al, 2018, Tumori Journal CrossRef
5. Treating EGFR-Mutated Oncogene-Addicted Advanced Non–Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
   Elena Fountzilas et al, 2018, Journal of Global Oncology CrossRef
6. EGFR mutation status in a series of Turkish non-small cell lung cancer patients
   Gizem Calibasi-Kocal et al, 2020, Biomedical Reports CrossRef
7. Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
   Agus Darwanto et al, 2017, BMC Cancer CrossRef
8. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved
   Sridhar Mishra et al, 2022, Pathology - Research and Practice CrossRef
9. Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer
   Edward Kim et al, 2018, Clinical Lung Cancer CrossRef
10. Profiling of in vivo, in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry
    Nasser S. Al-Shakliah et al, 2022, RSC Advances CrossRef
11. Tissue is the issue and tissue competition. Re‐biopsy for mutation T790: where and why?
    Paul Zarogoulidis et al, 2017, Clinical and Translational Medicine CrossRef
12. Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
    Paul Zarogoulidis et al, 2022, Respiratory Medicine Case Reports CrossRef
13. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla TM platform: a real-world two-center experience in Greece
    Kleita Michaelidou et al, 2024, Expert Review of Molecular Diagnostics CrossRef
14. EGFR Mutations Status For Non-Small-Cell Lung Cancer Patients
    Ieva Mirskytė et al, 2016, Sveikatos mokslai CrossRef
15. Radiogenomics: Lung Cancer-Related Genes Mutation Status Prediction
    Catarina Dias et al, 2019, Pattern Recognition and Image Analysis CrossRef